These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19139770)

  • 21. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
    Hong WS; Son YS
    Anticancer Res; 1996; 16(5A):3031-6. PubMed ID: 8917423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
    Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of over-expressed Smac gene coupling with cisplatin on proliferation and apoptosis of hepatocarcinoma cells].
    Guo CX; Li YB; DU HY; Liu Y; Sun L; Jin MH; Sun ZW
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):674-7. PubMed ID: 18822208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG
    Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells.
    Kobayashi T; Fujii T; Jo Y; Kinugawa K; Fujisawa M
    J Urol; 2004 May; 171(5):1929-33. PubMed ID: 15076314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin.
    Kishimoto S; Kawazoe Y; Ikeno M; Saitoh M; Nakano Y; Nishi Y; Fukushima S; Takeuchi Y
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):84-90. PubMed ID: 16044341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines.
    Cheng SC; Zhou J; Xie Y
    Cell Biol Int; 2005 Apr; 29(4):269-75. PubMed ID: 15914037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
    Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
    Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line.
    Asada N; Tsuchiya H; Ueda Y; Tomita K
    Anticancer Res; 1998; 18(3A):1765-8. PubMed ID: 9673402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modulation of cisplatin cytotoxicity by amphotericin B in six human cell lines of medullary thyroid cancer].
    Massart C; Gibassier J; Le Gall F; Raoul ML; Leclech G; Lucas C
    Bull Cancer; 1996 Aug; 83(8):619-25. PubMed ID: 8869041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
    Byun SS; Kim SW; Choi H; Lee C; Lee E
    BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line].
    Ohsaki Y; Ishida S; Fujikane T; Akiba Y; Osanai S; Onodera S
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1339-43. PubMed ID: 2369137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
    Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI
    Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.